202 related articles for article (PubMed ID: 36267313)
1. Construction and Validation of a Prognostic Model Based on mRNAsi-Related Genes in Breast Cancer.
Zhao X; Lin J
Comput Math Methods Med; 2022; 2022():6532591. PubMed ID: 36267313
[TBL] [Abstract][Full Text] [Related]
2. Immune- and Stemness-Related Genes Revealed by Comprehensive Analysis and Validation for Cancer Immunity and Prognosis and Its Nomogram in Lung Adenocarcinoma.
Chen M; Wang X; Wang W; Gui X; Li Z
Front Immunol; 2022; 13():829057. PubMed ID: 35833114
[TBL] [Abstract][Full Text] [Related]
3. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
Xu Q; Xu H; Chen S; Huang W
Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040
[No Abstract] [Full Text] [Related]
4. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
[TBL] [Abstract][Full Text] [Related]
5. Construction and validation of a prognostic model for stemness-related genes in lung adenocarcinoma.
Zhang H; Cao C; Xiong H
Transl Cancer Res; 2024 Mar; 13(3):1351-1366. PubMed ID: 38617509
[TBL] [Abstract][Full Text] [Related]
6. Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer.
Mao D; Zhou Z; Song S; Li D; He Y; Wei Z; Zhang C
Front Oncol; 2021; 11():626961. PubMed ID: 33747944
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma.
Zhang M; Wang X; Chen X; Guo F; Hong J
Front Genet; 2020; 11():441. PubMed ID: 32431729
[TBL] [Abstract][Full Text] [Related]
8. A Risk Signature with Nine Stemness Index-Associated Genes for Predicting Survival of Patients with Uterine Corpus Endometrial Carcinoma.
Xu H; Zou R; Liu J; Zhu L
J Oncol; 2021; 2021():6653247. PubMed ID: 33747079
[TBL] [Abstract][Full Text] [Related]
9. Construction of a Cancer Stem Cell related Histone Acetylation Regulatory Genes Prognostic Model for Hepatocellular Carcinoma via Bioinformatics Analysis: Implications for Tumor Chemotherapy and Immunity.
Dai Q; Zhu J; Yang J; Zhang CY; Yang WJ; Pan BS; Yang XR; Guo W; Wang BL
Curr Stem Cell Res Ther; 2024 Mar; ():. PubMed ID: 38561604
[TBL] [Abstract][Full Text] [Related]
10. Analyzing mRNAsi-Related Genes Identifies Novel Prognostic Markers and Potential Drug Combination for Patients with Basal Breast Cancer.
Huang K; Wu Y; Xie Y; Huang L; Liu H
Dis Markers; 2021; 2021():4731349. PubMed ID: 34646403
[TBL] [Abstract][Full Text] [Related]
11. mRNAsi Index: Machine Learning in Mining Lung Adenocarcinoma Stem Cell Biomarkers.
Zhang Y; Tseng JT; Lien IC; Li F; Wu W; Li H
Genes (Basel); 2020 Feb; 11(3):. PubMed ID: 32121037
[TBL] [Abstract][Full Text] [Related]
12. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
[TBL] [Abstract][Full Text] [Related]
13. A New Stemness-Related Prognostic Model for Predicting the Prognosis in Pancreatic Ductal Adenocarcinoma.
Huang XY; Qin WT; Su QS; Qiu CC; Liu RC; Xie SS; Hu Y; Zhu SY
Biomed Res Int; 2021; 2021():6669570. PubMed ID: 34671679
[TBL] [Abstract][Full Text] [Related]
14. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Prediction Using a Stemness Index-Related Signature in a Cohort of Gastric Cancer.
Chen X; Zhang D; Jiang F; Shen Y; Li X; Hu X; Wei P; Shen X
Front Mol Biosci; 2020; 7():570702. PubMed ID: 33134315
[TBL] [Abstract][Full Text] [Related]
16. Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma.
Zhou X; Dou M; Liu Z; Jiao D; Li Z; Chen J; Li J; Yao Y; Li L; Li Y; Han X
J Immunol Res; 2021; 2021():5518908. PubMed ID: 34426790
[TBL] [Abstract][Full Text] [Related]
17. Identification of key genes controlling breast cancer stem cell characteristics via stemness indices analysis.
Pei J; Wang Y; Li Y
J Transl Med; 2020 Feb; 18(1):74. PubMed ID: 32050983
[TBL] [Abstract][Full Text] [Related]
18. Construction and validation of a hypoxia-related gene signature to predict the prognosis of breast cancer.
Qiu C; Wang W; Xu S; Li Y; Zhu J; Zhang Y; Lei C; Li W; Li H; Li X
BMC Cancer; 2024 Apr; 24(1):402. PubMed ID: 38561760
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
[TBL] [Abstract][Full Text] [Related]
20. A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Wang Y; Han Y; Jin L; Ji L; Liu Y; Lin M; Zhou S; Yang R
Aging (Albany NY); 2024 Apr; 16(8):7293-7310. PubMed ID: 38656879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
